Hemoglobin Levels and Your Genetics
What is Hemoglobin Levels?
Hemoglobin is an iron-containing protein packed into red blood cells, and it performs one of the most vital tasks in the body: binding oxygen in the lungs and releasing it to every tissue that needs it. A single red blood cell carries roughly 270 million hemoglobin molecules, each capable of ferrying four oxygen atoms at a time. The result is an efficient delivery system that underpins everything from resting metabolism to peak athletic output.
Measured as grams per deciliter (g/dL) of blood, hemoglobin concentrations typically span 12–17 g/dL in adults, with ranges shifting by sex, age, and altitude. The figure in an ExomeDNA report reflects a genetically influenced set-point — a baseline the body tends toward absent illness, nutritional deficiency, or extreme environmental change. Because hemoglobin sits at the interface of iron metabolism, red blood cell production, and cell-surface biochemistry, the genetic landscape can shape it through several distinct pathways that current research is continuing to map.
The genetics behind Hemoglobin Levels
The strongest known genetic signal linked to hemoglobin variation in this study falls near ABO — the gene that defines the ABO blood group system. ABO encodes glycosyltransferases that place specific sugar residues on the surface of red blood cells and many other cell types. While blood type is the most familiar output of ABO, the gene's variants also modulate red blood cell membrane stability, erythrocyte lifespan, and the inflammatory environment in which red blood cells mature — each of which can influence the steady-state hemoglobin level the body maintains.
A second signal sits near A4GALT, which encodes an enzyme responsible for building the P(k) antigen — part of the P1PK blood group system — on red blood cell and endothelial surfaces. The glycan coat sculpted by A4GALT activity influences how red blood cells interact with the vascular wall and how efficiently they cycle through the spleen. Variants that alter this enzyme's activity have downstream effects on red blood cell survival and, consequently, on how much hemoglobin circulates at steady state.
A third signal in this study falls near ABCC8, an ATP-binding cassette transporter gene primarily known for its role in pancreatic beta cells. Its presence in a hemoglobin GWAS likely reflects the broader metabolic environment that supports erythropoiesis, reinforcing the finding that hemoglobin set-points emerge from a network of genetic influences rather than any single dominant locus.
Both the ABO and A4GALT signals reflect a consistent genetic theme: the biochemistry of the red blood cell surface — its glycan architecture, membrane rigidity, and signaling to the bone marrow — sets the stage for a long-term hemoglobin baseline.
What the research says
A 2024 genome-wide study examined hemoglobin concentration in a large population cohort using inverse-normal transformation of measurements, a statistical approach that allows researchers to detect genetic influences across the full distribution of levels — from naturally lower baselines to naturally higher ones [1]. This method is particularly well-suited to continuous biomarkers like hemoglobin, where meaningful genetic effects are distributed across the normal range rather than concentrated at clinical extremes.
Genome-wide studies of continuous hemoglobin levels have identified signals near blood group genes including ABO, underscoring that the genetic architecture determining blood type also shapes long-term oxygen-carrying capacity across populations. [1]
The findings reinforce an emerging picture of hemoglobin genetics: rather than a single dominant locus, the trait is influenced by a constellation of variants affecting red blood cell biology, iron metabolism, and erythropoiesis signaling. ABO and blood group-adjacent loci appear repeatedly across independent cohorts, suggesting the relationship between blood group biochemistry and hemoglobin set-point is a robust genetic phenomenon rather than a study-specific artifact.
Red blood cell membrane glycoproteins — including those encoded by ABO-adjacent loci — influence erythrocyte lifespan and turnover, creating a direct genetic link between blood group biology and the body's steady-state hemoglobin level. [1]
How Hemoglobin Levels affects you
Hemoglobin is the primary variable in blood's oxygen-carrying capacity. When it sits at the higher end of the natural range, tissues receive oxygen more efficiently during rest and exercise, which translates to sustained endurance, faster muscle recovery, and reduced breathlessness at altitude. When it sits at the lower end of the natural range, even a modest reduction can blunt energy production in cells that rely heavily on aerobic metabolism — particularly brain, heart, and skeletal muscle.
Because this trait carries a context-dependent flag, there is no universal "better" direction. A naturally higher hemoglobin baseline may be advantageous for endurance athletes or people living at altitude, while the same level can reflect dehydration or other factors in different contexts. A naturally lower baseline can reflect efficient iron recycling or simply a smaller red blood cell mass — neither inherently problematic absent accompanying symptoms or other laboratory findings.
The genetic result describes a set-point, not a ceiling or a floor. Environmental inputs — nutrition, hydration, altitude, exercise load, and underlying health status — move actual hemoglobin within the range the genome makes easiest to occupy.
Working with your profile
Understanding where a genetic baseline sits can inform how to approach the lifestyle factors that most reliably shift hemoglobin within the normal range. Iron is the most direct lever: the iron atom at the center of each hemoglobin molecule is the literal carrier of oxygen, and dietary iron — particularly heme iron from red meat, poultry, and seafood — is absorbed far more efficiently than non-heme iron from plant sources. Pairing plant-based iron foods with vitamin C meaningfully improves absorption by keeping iron in the more bioavailable ferrous form through the gut.
Vitamin B12 and folate support red blood cell production through a parallel mechanism — they are required for the DNA synthesis that allows bone marrow cells to divide rapidly enough to sustain a healthy erythrocyte supply. Deficiencies in either can depress hemoglobin independently of genetic baseline.
Endurance exercise generates adaptive pressure toward higher hemoglobin over weeks to months: the body responds to repeated oxygen demand by expanding its red blood cell mass. Altitude exposure — through residence, travel, or altitude-simulation training — triggers a similar adaptive response via erythropoietin signaling. People whose genetic baseline leans naturally lower often respond robustly to these stimuli once the underlying nutritional inputs are in place.
Routine complete blood count panels include hemoglobin and provide real-world feedback that genetic results can help contextualize but do not replace. Persistent readings outside the reference range for age and sex are worth discussing with a provider.
Related traits and genes
Hemoglobin does not operate in isolation. It is the output of a production line that begins with iron absorption in the gut — shaped by genes like HFE and TMPRSS6 — continues through heme synthesis involving ALAS2, and ends with bone marrow output regulated in part by erythropoietin signaling. Related ExomeDNA traits including Red Blood Cell Count, Ferritin, and Mean Corpuscular Volume each capture a different stage of this pipeline.
The ABO locus also appears in genetics research on platelet count, von Willebrand factor, and certain inflammatory markers — a reminder that blood group biochemistry is woven through a wide range of vascular biology beyond oxygen transport alone. Exploring Blood Type and cardiovascular traits alongside hemoglobin gives a fuller picture of how red blood cell biology fits into the broader system.